The Biohack Lab
- Ozone Therapy
- IV Therapy
- Neurofeedback Therapy
- Hyperbaric Oxygen Therapy (HBOT)
- Oxygen Therapy
Coral Gables, FL
Neurofeedback therapy in Coral Gables is offered at psychology practices, ADHD and autism clinics, and brain-performance centers, with neurology referrals often routed through University of Miami Health System and Baptist Health South Florida. Demand reflects an international and high-net-worth Latin-American patient base.
Neurofeedback uses EEG-based operant conditioning to train brain activity patterns, with variable evidence across ADHD, anxiety, PTSD, and post-concussion syndrome. It is FDA cleared as a biofeedback modality but not approved for specific psychiatric diagnoses. Clinics in Coral Gables, Florida vary in protocol (standard EEG, LORETA, qEEG-guided) and in whether they combine with psychotherapy. Florida Department of Health oversight of office-based surgery and regenerative medicine shapes which professionals can deliver neurofeedback and bill insurance.
With neurofeedback clinics on Regenerated.com in Coral Gables, patients can compare clinician credentials (licensed psychologist vs technician), qEEG mapping, and realistic outcome framing.
Regulatory context
Repetitive transcranial magnetic stimulation (rTMS) is regulated as a Class II prescription device. The first 510(k) clearance went to NeuroStar in 2008 for treatment-resistant major depressive disorder. Subsequent clearances expanded the on-label scope to obsessive-compulsive disorder (BrainsWay deep TMS, 2018), smoking cessation (BrainsWay, 2020), anxious depression as an adjunct indication (2021), and migraine via single-pulse TMS devices such as eNeura SpringTMS and SAVI Dual. Biofeedback instruments are cleared under 21 CFR 882.1425 as Class II devices for relaxation training and stress reduction. EEG-based neurofeedback systems hold 510(k) clearances in the same category. Cranial electrotherapy stimulation, tDCS wellness devices, and many vagus nerve stimulation accessories sold direct to consumers are not cleared as medical devices, and clinical claims beyond cleared indications are off-label.
The Florida Board of Medicine and Board of Osteopathic Medicine investigate TMS clinics for supervision deficiencies and off-label marketing, particularly claims around ADHD, autism, PTSD, and cognitive enhancement. The Florida attorney general has pursued Deceptive and Unfair Trade Practices Act actions against neurofeedback providers that made cure claims. Florida has a large wellness and integrative sector where CES, tDCS, and vagus nerve stimulation devices are offered, and these clinics draw board attention when marketing implies medical treatment beyond cleared indications. Insurers in Florida typically require documented failed antidepressant trials before covering TMS.
Explore related care